These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11155190)

  • 1. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Messmore HL
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():13-20. PubMed ID: 11155190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():7-11. PubMed ID: 11155189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A
    J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution.
    Nand S; Wong W; Yuen B; Yetter A; Schmulbach E; Gross Fisher S
    Am J Hematol; 1997 Sep; 56(1):12-6. PubMed ID: 9298861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
    Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
    Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer insights on the mechanism of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Prechel MM; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():57-67. PubMed ID: 15085467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia.
    Hoppensteadt DA; Walenga JM
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):1-18, v. PubMed ID: 18207062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia and thrombosis.
    Patel VP; Bong M; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2007 May; 36(5):255-60. PubMed ID: 17571830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Autoimmun Rev; 2002 May; 1(3):125-32. PubMed ID: 12849005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT).
    Jy W; Mao WW; Horstman LL; Valant PA; Ahn YS
    Thromb Haemost; 1999 Oct; 82(4):1255-9. PubMed ID: 10544909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of immune-mediated heparin-induced thrombocytopenia.
    Reilly RF
    Semin Dial; 2003; 16(1):54-60. PubMed ID: 12535302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia: an overview.
    Kelton JG
    Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allergic thrombocytopenia to heparin].
    Letawe-Gilis L; David JL
    Rev Med Liege; 2001 Jul; 56(7):489-92. PubMed ID: 11523299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia: implictions for cardiologist].
    Mattioli AV
    G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.